Media Coverage
Nanopass to begin trials with a device that may improve COVID-19 vaccines
Published in Globes
NanoPass developed the smallest FDA-approved microneedle
Published in TechTime. The needle, less than 1 millimeter, is manufactured using MEMS technology. It is intended for vaccines and painless medicines injection. The company announced production agreement with Korean M2N.
Nano-Pass has developed the world's smallest medical needle
Published in TechTime
Nanopass' intradermal device is ready for commercialization with Vaccines ( Kan 11 TV channel)
Israel's national broadcast service (Kan 11) interviewed Nanopass Technologies on its intradermal platform for its daily financial TV show.